EMN vs XBIO · P/E 21, rev $9.38B vs rev $1.5M
Eastman Chemical Company (EMN) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the EMN and XBIO stock pages for the full models.
Not investment advice.